Literature DB >> 21115606

Symptom variability in patients with severe COPD: a pan-European cross-sectional study.

R Kessler1, M R Partridge, M Miravitlles, M Cazzola, C Vogelmeier, D Leynaud, J Ostinelli.   

Abstract

In between exacerbations, chronic obstructive pulmonary disease (COPD) is usually regarded as a stable condition, but there is increasing recognition of variability in this state. This cross-sectional study assessed patients' perception of symptom variability. Participants were outpatients > 45 yrs old with COPD, current or ex-smokers, forced expiratory volume in 1 s (FEV₁) <50% predicted, FEV₁/forced vital capacity < 0.7 and no exacerbation leading to therapeutic intervention in the previous 3 months. Patients' perceptions of COPD symptoms and their impact on daily life activities were recorded. Alterations in therapy use in response to COPD worsening were also recorded. COPD symptoms were experienced by 2,258 (92.5%) out of 2,441 patients during the 7 days before interview. Breathlessness was the most common symptom (72.5%). Daily and/or weekly symptom variability was reported by 62.7% of symptomatic patients; the morning was the worst time of day. Factors associated with perception of variability of breathlessness included younger age, symptom severity and recruitment to the study by general practitioners. The perception of variability was significantly different between European countries or regions. Patient-perceived COPD symptoms vary over the day and the week, and impact on daily activities; morning being the worst time of day. The majority of patients appear not to adjust treatment when symptoms worsen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115606     DOI: 10.1183/09031936.00051110

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  117 in total

Review 1.  Drugs for chronic obstructive pulmonary disease.

Authors:  Christine Jenkins
Journal:  Aust Prescr       Date:  2017-02-01

Review 2.  [Management of refractory breathlessness in patients with advanced disease].

Authors:  C Bausewein
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

3.  Relationship of Patient Self-Administered COPD Assessment Test to Physician Standard Assessment of Chronic Obstructive Pulmonary Disease in a Family Medicine Residency Training Program.

Authors:  Jessica E Burchette; Ivy A Click; Leigh Johnson; S Alicia Williams; Brett Tyler Morgan
Journal:  J Patient Cent Res Rev       Date:  2019-07-29

Review 4.  The diagnosis of chronic obstructive pulmonary disease.

Authors:  Rainer Burkhardt; Wulf Pankow
Journal:  Dtsch Arztebl Int       Date:  2014-12-05       Impact factor: 5.594

5.  Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Authors:  Hana Müllerová; Mark T Dransfield; Byron Thomashow; Paul W Jones; Stephen Rennard; Niklas Karlsson; Malin Fageras; Norbert Metzdorf; Stefano Petruzzelli; Jean Rommes; Frank C Sciurba; Maggie Tabberer; Debora Merrill; Ruth Tal-Singer
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

6.  The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.

Authors:  Antoni Sicras-Mainar; Javier Rejas-Gutiérrez; Ruth Navarro-Artieda; Jordi Ibáñez-Nolla
Journal:  Lung       Date:  2014-05-10       Impact factor: 2.584

7.  Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.

Authors:  Patrícia Rebelo; Ana Oliveira; Cátia Paixão; Carla Valente; Lília Andrade; Alda Marques
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-29

8.  Objective Measurement of Cough Frequency During COPD Exacerbation Convalescence.

Authors:  Michael G Crooks; Yvette Hayman; Andrew Innes; James Williamson; Caroline E Wright; Alyn H Morice
Journal:  Lung       Date:  2015-08-18       Impact factor: 2.584

9.  Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies.

Authors:  MeiLan K Han; Anna W Steenrod; Elizabeth D Bacci; Nancy K Leidy; David M Mannino; Byron M Thomashow; R G Barr; Barry J Make; Russ P Bowler; Stephen I Rennard; Julia F Houfek; Barbara P Yawn; Catherine A Meldrum; John W Walsh; Fernando J Martinez
Journal:  Chronic Obstr Pulm Dis       Date:  2015

10.  [Chronic obstructive pulmonary disease : new pharmacotherapeutic options].

Authors:  T Greulich; A R Koczulla; C Vogelmeier
Journal:  Internist (Berl)       Date:  2012-11       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.